C Noel Bairey Merz (Director of the Barbra Streisand Women’s Heart Center at the Smidt Heart Institute at Cedars-Sinai, CA, USA) discusses the unmet needs in women’s cardiovascular health, including low survival rates following a heart attack and improving the enrolment of women in clinical trials.
Speaker’s disclosures: C Noel Bairey Merz has received honoraria and consultancy fees from ACRWH (NIH advisory council), NIH-CASE (grant review study section), book honoraria from Springer International and Decision Support in Medicine LLC and is a board director for iRhythm. She has also received honoraria and consultancy fees to Cedars-Sinai Medical Center from American College of OB-GYN, Atlantic Health System, Abbott Diagnostics, American College of Cardiology, Cardio NAH Health System, Expert Exchange, INOVA, George Washington University, Med Ed, Northwestern, Pri-Med, Oklahoma Chapter of the American College of Cardiology, Renown Health System, Reno, San Diego Heart Institute, Society of Vascular Medicine, St Francis Medical Center, Hartford, University of Minnesota, UCSF, University of Capetown, University of Colorado.
- What are the major unmet needs in women’s cardiovascular health? (0:09)
- What reasons have been identified for the lower heart attack survival rates in women compared to men? (0:55)
- How can we improve the enrolment of women in clinical trials? (2:07)
- What treatment options are available for women with ischemia with no obstructive coronary artery disease? (4:30)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with Arrhythmia Alliance.
Share this Video
Related Videos In Cardiovascular Disease
William Schulyer-Jones, ACC 2021 – Findings from the ADAPTIVE study
We were delighted to speak with Dr William Schulyer-Jones (Associate Professor of Medicine, Duke University School of Medicine, Durham, NC, USA) about the findings of the ADAPTABLE STUDY, a large randomized study assessing the benefits and long-term effectiveness of aspirin dosage (81 mg vs. 325mg) for patients with cardiovascular disease. Abstract title: Aspirin Dosing: A […]
Gustavo Samaja, ESC 2020 – Myocardial Infarction with no Obstructive Coronary Arteries
We spoke to Dr Gustavo Samaja (Policlinico Bancario, Buenos Aires, Argentina) about myocardial infarction with no obstructive coronary arteries (MINOCA), and especially its prevalence and importance during the COVID-19 pandemic. Questions Could you give us a brief overview of myocardial infarction with no obstructive coronary arteries (MINOCA)? (0:33) How prevalent is MINOCA and what […]
David Playford, ESC 2020 – Diastolic Function and Mortality Part 1
We spoke to Professor David Playford (University of Notre Dame, Perth, Australia) regarding diastolic function and dysfunction, the National Echo Database Australia (NEDA), and then focused on his recent study on diastolic function and mortality. Questions What are the prognostic implications of diastolic dysfunction? (0:07) How do you classify patients by diastolic function? (1:18) […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!